RecruitingClonal Hematopoiesis
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.
Sponsor: Vanderbilt-Ingram Cancer Center
You may qualify if…
- ✓ Patient greater than or equal to 18 years old at time of consent
- ✓ Able to provide informed consent
- ✓ Idiopathic cytopenia (ICUS) or idiopathic cytoses (elevated blood counts without disease or explanation); clonal cytopenia of undetermined significance (CCUS), clonal hematopoiesis of indeterminate potential (CHIP) or individuals at higher risk for clonal hematopoiesis (ex. patients with known diagnosis of solid tumors or cardiovascular disease)
You may not qualify if…
- ✕ Unable to provide consent
- ✕ Diagnosis of active hematologic malignancy. For example, a diagnosis of CMML, AML, MDS, MPN; History of hematologic malignancy is NOT exclusionary if in complete remission (e.g. previous myeloma or lymphoma)
Where it's recruiting
Tennessee
Nashville
Source: ClinicalTrials.gov · NCT06701214 · last updated 2026-09-23